Search company, investor...
iMatrix company logo

iMatrix

imatrix.com

Founded Year

2002

Stage

Acquired | Acquired

About iMatrix

iMatrix provides digital marketing solutions for healthcare professionals in the eye care, chiropractic, and veterinary industries. The company's products are Chiromatrix and Vetmatrix. It was founded in 2002 and is based in San Diego, California. In January 2014, Internet Brands acquired iMatrix. The terms of the transaction were not disclosed.

Headquarters Location

5550 Morehouse Drive

San Diego, California, 92121,

United States

Missing: iMatrix's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: iMatrix's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

iMatrix Patents

iMatrix has filed 6 patents.

The 3 most popular patent topics include:

  • Integers
  • Spamming
  • Algebraic graph theory
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/28/2016

3/22/2022

Natural language processing, Email, Machine learning, Computational linguistics, Spamming

Grant

Application Date

11/28/2016

Grant Date

3/22/2022

Title

Related Topics

Natural language processing, Email, Machine learning, Computational linguistics, Spamming

Status

Grant

Latest iMatrix News

Laminin Isoforms Range Expanded

Sep 5, 2022

Designed to efficiently induce differentiation in ES and iPS cells,  AMSBIO  has expanded its iMatrix series of recombinant laminin E8 fragments to now include laminin isoforms LN-111 and LN-332. This expanded range of laminin isoforms (LN-111, 332, 511, 411 and 221) now provides even greater flexibility and control when tailoring your substrate to the requirements of specific cultured cells. Proven in many leading life science research labs – iMatrix is used as a substrate for culturing and maintaining cells, including Pluripotent Stem Cells and Mesenchymal Stem Cells, as well as for differentiation into ectoderm, endoderm, and mesoderm. All iMatrix products offer the dual advantage of recombinant protein expression and as E8 fragments they contain all of the integrin-binding sites of full-length laminin in a much shorter protein. New to the product range, iMatrix-111 is the E8 fragment of the LN-111 laminin isoform, which plays significant roles in vivo and is important in cell culture. As well as being the major substrate for nerve axon growth, both in vivo and in vitro, LN-111 is also the main component of the industry standard substrates used in cell culture: Matrigel and Cultrex BME. iMatrix-111 has been validated for to promote differentiation of iPSCs into hepatocyte-like cells. The Laminin-332 isoform is essential for epithelial cell adhesion to the basement membrane and iMatrix Laminin-322 has been used to induce differentiation of iPS cells into corneal epithelial cells in vitro . Featured Image: ACE2-expressing iPS cells grown with iMatrix-511 as ECM in StemFit medium; infected with SARS-CoV-2 virus after cryopreservation in STEM CELLBANKER. Green: SARS-CoV-2 N protein, Red: OCT3/4, Blue: DAPI. Photo: Courtesy of Kazuo Takayama (CiRA, Kyoto University, Japan) Share:

iMatrix Frequently Asked Questions (FAQ)

  • When was iMatrix founded?

    iMatrix was founded in 2002.

  • Where is iMatrix's headquarters?

    iMatrix's headquarters is located at 5550 Morehouse Drive, San Diego.

  • What is iMatrix's latest funding round?

    iMatrix's latest funding round is Acquired.

  • Who are the investors of iMatrix?

    Investors of iMatrix include Internet Brands.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.